NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $581,386 | -26.2% | 30,249 | -2.4% | 0.00% | 0.0% |
Q2 2023 | $787,512 | -32.6% | 30,980 | -4.1% | 0.00% | -50.0% |
Q1 2023 | $1,168,296 | -8.1% | 32,318 | +0.7% | 0.00% | 0.0% |
Q4 2022 | $1,271,160 | +18.0% | 32,100 | +38.9% | 0.00% | 0.0% |
Q3 2022 | $1,077,000 | -23.2% | 23,106 | -27.7% | 0.00% | -33.3% |
Q2 2022 | $1,402,000 | -15.5% | 31,979 | +39.4% | 0.00% | 0.0% |
Q1 2022 | $1,660,000 | -27.7% | 22,947 | -19.0% | 0.00% | 0.0% |
Q4 2021 | $2,296,000 | -45.7% | 28,315 | -22.1% | 0.00% | -57.1% |
Q3 2021 | $4,229,000 | -31.3% | 36,342 | -2.2% | 0.01% | -30.0% |
Q2 2021 | $6,160,000 | +37.7% | 37,155 | +15.9% | 0.01% | +25.0% |
Q1 2021 | $4,472,000 | +8.0% | 32,056 | +34.1% | 0.01% | 0.0% |
Q4 2020 | $4,139,000 | +50.2% | 23,908 | +20.9% | 0.01% | +33.3% |
Q3 2020 | $2,756,000 | +42.2% | 19,781 | +22.0% | 0.01% | +50.0% |
Q2 2020 | $1,938,000 | +41.2% | 16,219 | +18.1% | 0.00% | 0.0% |
Q1 2020 | $1,373,000 | -19.9% | 13,734 | -5.8% | 0.00% | +33.3% |
Q4 2019 | $1,714,000 | – | 14,578 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |